Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Recent Progress in Pharmacogenomics of Antipsychotic Drug Response.

Current psychiatry reports - 27 Mar 2018

Zhang Jian-Ping, Malhotra Anil K

Abstract excerpt

PURPOSE OF REVIEW: Pharmacogenomics (PGx) of antipsychotic drug response is an active area of research in the past few years. We reviewed recent PGx studies with an emphasis of development of new methodologies and new research directions. RECENT FINDINGS: Traditional candidate gene approach continues to generate evidence to support the associations of antipsychotic response with genes coding for drug targets such...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antipsychotic Agents
Share to Genome-Wide Association Study
Share to Molecular Targeted Therapy

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Multifactorial Inheritance

Share to Pharmacogenetics

Share to Phenotype

Share to Psychotic Disorders

Share to Schizophrenia

Source

Identifiers

PMID: 29589131
DOI: 10.1007/s11920-018-0886-y

Genes

DRD2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Recent Progress in Pharmacogenomics of Antipsychotic Drug Response.PMID 29589131Read ↗

Pharmacogenomics and schizophrenia.Semantic proximity Read ↗

Toward understanding genetic risk for differential antipsychotic response in individuals with schizophreniaSemantic proximity Read ↗

Pharmacogenomics: a path to predictive medicine for schizophrenia.Semantic proximity Read ↗

Genomics and the future of pharmacotherapy in psychiatrySemantic proximity Read ↗

Pharmacogenomics of psychiatric drug treatment.Semantic proximity Read ↗

Pharmacogenetics and antipsychotics: therapeutic efficacy and side effects prediction.Semantic proximity Read ↗

Pharmacogenomics of antipsychotics efficacy for schizophreniaSemantic proximity Read ↗

Preliminary evidence for association of genome-wide significant DRD2 schizophrenia risk variant with clozapine response.Semantic proximity Read ↗

Pharmacogenetics-Guided Advances in Antipsychotic Treatment.Semantic proximity Read ↗

Delineating significant genome-wide associations of variants with antipsychotic and antidepressant treatment response: implications for clinical pharmacogenomics.Semantic proximity Read ↗

Pharmacogenomics can improve antipsychotic treatment in schizophreniaSemantic proximity Read ↗

The identification of novel genetic variants associated with antipsychotic treatment response outcomes in first-episode schizophrenia patients.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.